Arjuna granted new patent in Europe
Arjuna Natural Ltd. has been granted a new patent in Europe for its applied technology of improving the bioavailability of curcumin in its Curcugreen® formulation—a product in its portfolio of natural ingredients. The concern for curcumin is that it’s not absorbed nor retained well in the blood stream. The market has subsequently been flooded with curcumin products laden with synthetic additives in attempts to overcome the issue of bioavailability. This patent-protected composition of turmeric delivers free curcumin into blood and is retained in the body for longer duration, offering new light to bioavailability concerns.
Read more at Vitafoods Insights
Unilever puts its toe into the CBD market
Unilever will be taking its first step in the US hemp market in September through one of its subsidiary brands. Schmidt's Naturals is set to launch a line of hemp-oil deodorants that will be available at select retailers. That line will be followed later in the fall by a range of CBD products
Read more at BNN Bloomberg
Nestlé held to account over baby formula claims
A new report from the Changing Markets Foundation and SumOfUs reveals that Nestlé has failed to act on a number of criticisms relating to the composition and claims of its baby milk formula products – despite making commitments last year to tackle the issue. Nestlé is also found to market its products as being close to breastmilk or inspired by human milk, in breach of the World Health Organization Marketing Code and subsequent resolutions. Nestlé held to account for inaction.
Read more at Changing Markets
Givaudan publishes its first-quarter sales report
Six months after the acquisition of Naturex, Givaudan has published its 2019 first-quarter sales report. In the first three months of 2019 Givaudan recorded sales of CHF 1,525 million (£1,16m), an increase of 6.3% on the previous year. Fragrance Division sales were CHF 677 million (£516m), an increase of 8.7% on a like-for-like. Flavour Division sales were CHF 848 million (£647m), an increase of 4.3% on a like-for-like basis. Givaudan states it has started the year with good business momentum and growth across all product segments and geographies. Key strategic focus areas are naturals, health and wellbeing, active beauty, and integrated solutions.
Read more at Givaudan
